Many tumour markers now coming into clinical use for diagnosing gastrointestinal cancers are carbohydrateassociated antigens. One such marker, sialosyl-Tn (STn), is a carbohydrate-associated antigen found on mucin-type glycoproteins (Hakomori, 1989) . Using monoclonal antibody (MAb) TKH2, specific for the STn epitope (Kjeldsen et al., 1988) , we previously observed that in colonic tissues this antigen was not expressed by normal mucosa, but expression increased in premalignant lesions (adenomas, chronic ulcerative colitis) and approached 87-90% sensitivity in colon cancer tissues (Itzkowitz et al., , 1990 Thor et al., 1989) . Furthermore, in colon cancer tissues, STn expression was found to be an independent predictor of outcome such that patients with STn-negative tumours had an excellent overall and disease-free survival regardless of tumour stage (Itzkowitz et al., 1990) .
Little is known about STn expression in normal or malignant gastric tissues. The purpose of this investigation was to shed light on STn distribution in normal and abnormal gastric tissue, and correlate STn expression with survival in patients with gastric cancer.
Materials and methods

Clinical material
We studied 31 patients who underwent surgical resection for gastric cancer between 1974 and 1984 in whom pathological, clinical and long-term outcome data as well as pathology specimens were available. Eleven patients received no postsurgical therapy, 15 patients were treated with adjuvant chemotherapy after curative resection and five patients received chemotherapy for unresectable or metastatic disease. Deaths not attributed to gastric cancer were verified by clinical follow-up and imaging studies. Table I lists the clinicopathological data on the patients. The 11 non-caucasian patients included four black, four Hispanic and three oriental individuals. Tumour size and the presence of involved lymph nodes were known for all subjects, although complete staging information was not available for some patients. Five patients had uninvolved lymph nodes; all others had tumour which spread to lymph nodes or other metastatic sites. The mean follow-up period was 46 months (range 9-168 months).
Archival paraffin-embedded tissues were retrieved from Pathology Department files, and sections 5 jsm thick were prepared for immunohistochemical staining. One represen- 
Immunohistochemistry
Monoclonal antibody TKH2 (IgGI), which specifically reacts with the sialosyl-Tn antigen (Kjeldsen et al., 1988) , was kindly provided by Dr Sen-itiroh Hakomori (The Biomembrane Institute, Seattle, WA, USA).
Slides were stained using previously described methods (Itzkowitz et al., 1990) . Negative controls consisted of substituting mouse IgGl for MAb TKH2, which resulted in no staining.
Scoring of antigen expression Slides were interpreted for STn antigen expression without knowledge of clinicopathological or outcome data. Scoring was performed by examining all low-power optical fields (10 x objective) containing tumour and estimating the percentage of antigen-positive cells. A tumour was considered positive if more than 5% of cells expressed STn antigen.
Results
Sialosyl-Tn expression in normal gastric mucosa and intestinal metaplasia STn antigen was not expressed by cells of normal gastric mucosa except for parietal cells, which exhibited STn expression in intracellular canalicular membranes (Figure la) . Mucus-secreting cells of foveolar epithelium, deep gastric glands, and mucous neck cells were all devoid of STn expression. In sharp contrast, the mucin in goblet cell vacuoles from cases of intestinal metaplasia (n = 13) exhibited strong STn expression (Figure lb T4 N, Mo poorly differentiated adenocarcinoma involving the perigastric fat and distal margin of resection and died 25 months later despite adjuvant radiotherapy and FAME (5-fluorouracil, adriamycin, methyl-CCNU). In both the sialosylTn-positive and sialosyl-Tn-negative groups, all five patients without lymph node metastases (asterisks in Tables I and II) were among the individuals with a favourable outcome.
Of the 11 patients with T2 lesions, none of the five that had STn-negative tumours died of their disease, whereas four of the six with STn-positive tumours did. Of the 14 patients with T3 lesions, one of three patients with STn-negative tumours died of the disease, whereas 9 of 11 patients with STn-positive tumours died of the disease. All three patients with T4 tumours died of gastric cancer, whereas neither of the two patients with T, tumours did.
The clinical status of patients according to degree of sialosyl-Tn expression is depicted in Figure 2 Among the patients with STn-negative tumours, 6 of 10 (60%) have survived 5 years or more (Figure 2 ). Of the eight deaths in this group, only two were attributable to gastric cancer.
Discussion
Sialosyl-Tn is a simple mucin-type carbohydrate antigen which has a very restricted distribution in the body. In fact, only goblet cells of the small intestine, parietal cells of the stomach, testicular Leydig cells and some endothelial cells express STn (Kjeldsen et al., 1988) . On the other hand, adenocarcinomas of several epithelial organs frequently express STn. Moreover, expression of STn by colon cancers and ovarian cancers has been associated with a poor survival (Itzkowitz et al., 1990; Kobayashi et al., 1992) . This suggests that STn expression by cancer cells plays an important role in the biology of the tumour.
In the present study, 68% of primary gastric adenocarcinomas expressed STn. This is consistent with earlier studies reporting the prevalence of STn expression in gastric cancer tissues as ranging between 71 and 100% Thor et al., 1986; Kjeldsen et al., 1988; Nakasaki et al., 1989; David et al., 1992) . The tendency for a tumour to express STn in our study did not depend upon patient age, sex, tumour location, tumour stage or degree of differentiation. Likewise, Ohuchi et al. (1986) found no correlation between STn expression and degree of differentiation, and David et al. (1992) found no association between STn expression and histological type, growth pattern, lymphoid infiltrate, lymph node metastasis, venous invasion and ploidy status in gastric cancers. They thus concluded that STn may not be a marker of tumour aggressiveness. However, as we have previously noted in colon cancer (Itzkowitz et al., 1990) , and now report in gastric cancer, STn expression does not have to correlate with histopathological features in order to serve as a useful marker of an adverse outcome. In fact, for a new marker of prognosis to enhance upon existing prognostic pathological features it should be independent of those features. STn has been detected at abnormally high levels in the serum of 28-59% of gastric cancer patients (Farinati et al., 1989; Heptner et al., 1989; Correale et al., 1991; Guadagni et al., 1991 Guadagni et al., , 1992 Motoo et al., 1991) , and in this disease STn (defined as CA72-4 antigen) is a more sensitive and specific marker than either carcinoembryonic antigen or CA19-9 (Heptner, et al., 1989; Guadagni et al., 1992) . Moreover, elevated circulating STn levels may predict the development of recurrent gastric cancer after surgical resection more accurately than CEA (Guadagni et al., 1991 (Guadagni et al., , 1992 . It seems, however, that only late-stage gastric carcinomas are associated with elevated serum STn levels (Guadagni et al., 1991 (Guadagni et al., , 1992 . It is not yet clear why patients with STn-positive tumours should have a worse prognosis than those with STn-negative tumours. Sialomucins have been shown in colon cancer model systems to be important in metastasis (Bresalier et al., 1991) , and most metastases of gastric cancer express STn (David et al., 1992) . In addition, mucins bearing STn antigen can mediate inhibition of natural killer cell cytotoxicity, thereby providing a mechanism for immune escape (Ogata et al., 1992) .
